Atlas Trials

A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

Clinical trial NCT00035230 · COMPLETED

Trial details

NCT number
NCT00035230
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bipolar Disorder
Start date
2001-07-01
Enrollment
338

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.